阅读说明：本技术 一种液体生物样品中选择性去除宿主核酸的方法 (Method for selectively removing host nucleic acid from liquid biological sample ) 是由 江山 庞白冰 于 2019-11-15 设计创作，主要内容包括：本发明提供了一种液体生物样品中选择性去除宿主核酸的方法,属于分子生物学、体外分子诊断技术领域,所述方法包括如下步骤：(1)将液体生物样品与皂苷溶液混合均匀,室温下静置5-30分钟,使宿主细胞等非目标成分的细胞特异性裂解,得混合物,混合物中皂苷的终浓度为0.02-1.7％；(2)将混合物高速离心,离心后倒掉上清液,得到第一沉淀；(3)向第一沉淀中加入核酸酶反应液和核酸酶,核酸酶包含10-200个酶单位,目的是降解样品中非目标成分,以宿主核酸为主；(4)将核酸酶灭活；(5)富集目标微生物2。可以检测出浓度低至约2.0CFU/mL的致病菌,满足对诸如血流感染等感染性疾病的临床诊断要求；本发明所使用的试剂和设备少,成本低,工艺简单,应用范围广泛。(The invention provides a method for selectively removing host nucleic acid from a liquid biological sample, belonging to the technical field of molecular biology and in-vitro molecular diagnosis, and comprising the following steps: (1) mixing liquid biological sample and saponin solution, standing at room temperature for 5-30 min to specifically lyse host cells and other non-target components to obtain mixture with saponin concentration of 0.02-1.7%; (2) centrifuging the mixture at a high speed, and pouring out supernatant after centrifugation to obtain a first precipitate; (3) adding a nuclease reaction solution and a nuclease into the first precipitate, wherein the nuclease contains 10-200 enzyme units and aims at degrading non-target components in the sample and takes host nucleic acid as the main component; (4) inactivating nuclease; (5) the target microorganism 2 is enriched. Pathogenic bacteria can be detected at a concentration as low as about 2.0CFU/mL, and clinical diagnosis requirements for infectious diseases such as bloodstream infection are met; the invention has the advantages of less used reagents and equipment, low cost, simple process and wide application range.)

1. A method for selectively removing host nucleic acids from a liquid biological sample, comprising: the method comprises the following steps:

(1) uniformly mixing the liquid biological sample with the saponin solution, standing for 5-30 minutes at room temperature to obtain a mixture, wherein the final concentration of saponin in the mixture is 0.02-1.7%;

(2) centrifuging the mixture at a high speed, and pouring out supernatant after centrifugation to obtain a first precipitate;

(3) adding a nuclease reaction solution and a nuclease to the first precipitate, the nuclease comprising 10 to 200 enzyme units;

(4) inactivating nuclease;

(5) the target microorganism 2 is enriched.

2. The method of claim 1 for selectively removing host nucleic acids from a liquid biological sample, wherein: after step (3) enriching the target microorganism 1, washing the target microorganism 1 with water and/or a biological buffer, followed by step (4).

3. The method of claim 2 for selectively removing host nucleic acids from a liquid biological sample, wherein: the biological buffer solution comprises one of PBS, TE, TBE, TAE and Tris-glycine buffer solution.

4. The method of claim 1 for selectively removing host nucleic acids from a liquid biological sample, wherein: the final concentration of the saponin in the mixture in the step (1) is 0.04-0.85%.

5. The method of claim 1 for selectively removing host nucleic acids from a liquid biological sample, wherein: the rotation speed of the centrifugation in the step (2) is 4000-10000 rpm, and the time is 20-30 minutes.

6. The method of claim 1 for selectively removing host nucleic acids from a liquid biological sample, wherein: the nuclease in the step (3) contains 50-150 enzyme units.

7. The method of claim 2 for selectively removing host nucleic acids from a liquid biological sample, wherein: repeating the step (3) at least once.

8. The method of claim 7 for selectively removing host nucleic acids from a liquid biological sample, wherein: repeating the step (3) for 2 times.

9. Use of a method for selectively removing host nucleic acids from a liquid biological sample according to any one of claims 1 to 8 in the preparation of a diagnostic kit.

10. Use according to claim 9, characterized in that: the diagnostic kit is used for isolating a microorganism of interest and/or isolating a nucleic acid of a microorganism of interest in a liquid biological sample comprising the microorganism of interest, non-target cells and optionally fragments of the microorganism of interest and/or non-target cells, the diagnostic kit comprising at least one saponin preparation, at least one enzyme capable of cleaving nucleic acids, EDTA and/or EGTA and/or DTT and/or β -mercaptoethanol and/or DEPC and/or guanidine.

Technical Field

The invention relates to the technical field of molecular biology and in-vitro molecular diagnosis, in particular to a method for selectively removing host nucleic acid from a liquid biological sample.

Background

Pathogenic microorganisms such as bacteria, mycoplasma, chlamydia, rickettsia and spirochetes are the main causative factors of infection and infectious diseases, which enter the human body through contact or other agents, causing the disease to occur. During the course of the infectious disease process, a proportion of the pathogens may enter the patient's blood circulation via various routes, either in different types of body fluids such as cerebrospinal fluid, fluid accumulations, pus etc. from organs in the body, or in organ lavages deliberately obtained by medical means such as bronchoalveolar lavages. Thus, liquid biological samples taken from these various sources have become an effective way to diagnose infectious pathogens present in the body.

However, the number of pathogens that can enter each of these types of biological fluids is often small, especially in the early stages of disease development. For example, in a blood-infected patient, the concentration of pathogenic bacteria in the blood sample may be only 1-5 Colony Forming Units (CFU) per ml of sample. Meanwhile, the blood sample contains a large amount of host cells and cell debris such as red blood cells, white blood cells, platelets and the like, wherein the number of the white blood cells can exceed 4,000,000 per milliliter.

The diagnosis of the presence of a pathogen in a sample is achieved by detecting the nucleic acid of the pathogen, and molecular biological diagnostic techniques enable the rapid, sensitive and specific detection of pathogenic microorganisms present in a liquid biological sample. The current method is to first lyse all cells in a liquid biological sample, including host cells and target pathogenic microorganisms, and then extract the total nucleic acids in the sample for molecular diagnostics. However, the presence of a large amount of host cells and their fragments and released free nucleic acids in a liquid biological sample such as blood, together with the scarcity of the number of pathogenic microorganisms as targets for detection, makes it difficult to diagnose pathogenic microorganisms causing diseases such as blood infection by molecular biological methods. The specific reasons include:

first, high concentrations of host nucleic acids released upon lysis of host cells in a sample may compete for nucleic acid capture materials, affecting the efficiency of extraction of pathogenic microbial nucleic acids.

Secondly, the high concentration of host nucleic acid may compete for the primers, enzymes, etc. of the reaction during the amplification reaction (PCR reaction) of the target pathogenic microorganism nucleic acid sequence, which may result in the generation of a large amount of non-specific amplification products and inhibit the amplification of the target pathogenic microorganism nucleic acid sequence.

Third, when a high throughput sequencing (NGS) method is used to detect a target pathogenic microorganism, a high concentration of host nucleic acid causes the host nucleic acid sequence to occupy most of the sequencing data, thereby occupying and compressing the amount of sequencing data of the target pathogenic microorganism nucleic acid sequence, and reducing the sensitivity and accuracy of detection. For the above reasons, most of the currently available methods and kits for separating and detecting target microorganisms in biological samples are not suitable for liquid biological samples, and thus, there is a strong need in the field of clinical laboratory for methods and kits suitable for separating and identifying minute amounts of pathogenic microorganisms in large volume of liquid biological samples.

Disclosure of Invention

In view of the above-mentioned shortcomings of the currently available methods and kits for isolating and detecting target microorganisms in biological samples, which are mostly unsuitable for liquid biological samples, the present invention provides a method for selectively removing host nucleic acids from a liquid biological sample.

A method for selectively removing host nucleic acids from a liquid biological sample, the method comprising the steps of:

(1) mixing liquid biological sample and saponin solution, standing at room temperature for 5-30 min to specifically lyse host cells and other non-target components to obtain mixture with saponin concentration of 0.02-1.7%;

(2) centrifuging the mixture at a high speed, and pouring out supernatant after centrifugation to obtain a first precipitate;

(3) adding a nuclease reaction solution and a nuclease into the first precipitate, wherein the nuclease contains 10-200 enzyme units and aims at degrading non-target components in the sample and takes host nucleic acid as the main component;

(4) inactivating nuclease;

(5) the target microorganism 2 is enriched.

The liquid biological sample comprises target microorganisms with intact cell wall structures and non-target components including free nucleic acids in the sample, cells without cell wall structures and cell fragments containing nucleic acids.

In the technical scheme of the application: firstly, the saponin carries out cracking on host cells in a liquid biological sample to obtain a mixture, a first precipitate is obtained through high-speed centrifugation, nuclease is added for digestion, then the nuclease is inactivated, and the target microorganism 2 is obtained through enrichment.

In the application, on one hand, the effective final concentration of the saponin used for cracking the host cells in the liquid biological sample is between 0.02% and 1.7%, and when the final concentration of the saponin is more than 1.7%, the extraction yield of the target microorganism nucleic acid is reduced sharply and even reaches the undetectable degree, and on the other hand, the used nuclease is inactivated and removed.

The method of the invention can detect pathogenic bacteria with the concentration as low as about 2.0CFU/mL, and meets the clinical diagnosis requirement of infectious diseases such as bloodstream infection.

The invention has the advantages of less used reagents and equipment, low cost, simple process and wide application range.

Preferably, the nuclease comprises a DNA-digesting enzyme and/or an RNA-digesting enzyme.

Preferably, step (3) is followed by enrichment of target microorganism 1, washing of target microorganism 1 with water and/or a biological buffer, and then step (4).

More preferably, the biological buffer comprises one of PBS, TE, TBE, TAE and Tris-glycine buffer.

Preferably, the final concentration of saponin in the mixture of step (1) is 0.02-1.0%.

More preferably, the final concentration of saponin in the mixture of step (1) is 0.04-0.85%.

Preferably, the rotation speed of the centrifugation in the step (2) is 4000-10000 rpm, and the time is 20-30 minutes.

Preferably, the nuclease in step (3) comprises 50 to 150 enzyme units.

Preferably, step (3) is repeated at least once.

More preferably, step (3) is repeated 2 times. And 2 times, the sample is treated by the nuclease, so that the flow greatly reduces the number of the nuclease required for digesting the host nucleic acid and the time consumed by reaction, protects the target microorganism in the sample to the maximum extent, and obtains good target microorganism nucleic acid extraction benefit.

Preferably, the first precipitate obtained in the step (2) is uniformly mixed with nuclease reaction liquid and nuclease, then is placed at 37 ℃ for reaction for 30 minutes, then is centrifuged at 12000rpm for 5 minutes, and the supernatant is discarded to obtain a second precipitate;

adding nuclease reaction liquid and nuclease into the second precipitate, mixing uniformly, placing at 37 ℃ for reacting for 30 minutes, then adding 25-100 mu L of 100mM EDTA, mixing uniformly, keeping at 40-80 ℃ for 2-15 minutes, then centrifuging at 12000rpm for 5 minutes, and discarding the supernatant to obtain a third precipitate.

The third precipitate contains part or all of the target microorganisms in the liquid biological sample treated by the method of the present invention, and can be used for further detecting and/or quantifying the target microorganisms in the liquid biological sample by methods including, but not limited to, Polymerase Chain Reaction (PCR), reverse transcription-polymerase chain reaction (RT-PCR), nucleic acid hybridization-based reactions such as DNA chip hybridization, DNA sequencing, and microorganism culture identification.

More preferably, step (3) is repeated 3 times.

Preferably, the method for inactivating the nuclease in the step (4) comprises adding EDTA and/or EGTA and/or DTT and/or DEPC and/or guanidine.

Preferably, the nuclease in the step (4) is inactivated by raising the temperature to 40-80 ℃ for 2-15 minutes.

More preferably, the method for inactivating the nuclease in the step (4) is to raise the temperature to 60 ℃ and keep the temperature for 10 minutes

The method for selectively removing host nucleic acid from a liquid biological sample is used for preparing a diagnostic kit.

The diagnostic kit is used for isolating a microorganism of interest and/or isolating a nucleic acid of a microorganism of interest in a liquid biological sample comprising the microorganism of interest, non-target cells and optionally fragments of the microorganism of interest and/or non-target cells, the diagnostic kit comprising at least one saponin preparation, at least one enzyme capable of cleaving nucleic acids, EDTA and/or EGTA and/or DTT and/or β -mercaptoethanol and/or DEPC and/or guanidine.

In the technical scheme of the application:

PBS: phospate buffer saline, Phosphate buffered saline;

TE：Tris-HCl-EDTA；

TBE：Tris-borate-EDTA；

TAE：Tris-acetate-EDTA；

EDTA: ethylene diamine tetraacetic acid;

EGTA: ethylene glycol bis-tetraacetic acid;

DTT: dithiothreitol;

DEPC: diethyl cokenate;

CFU represents colony forming units;

host: a biological subject, in particular a human, from which a liquid biological sample is derived;

host cell: cells derived from a host contained in a liquid biological sample;

host cell nucleic acids or host nucleic acids correspond to the nucleic acids (DNA and RNA) contained in the above-mentioned host cells or fragments thereof;

a target microorganism: including all microorganisms that do not contain a readily cleavable outer cholesterol membrane, which may be pathogenic, especially to humans, including viruses (other than enveloped viruses), bacteria, fungi, chlamydia, mycoplasma, rickettsia, and also other animals that are microscopic;

the target microorganism nucleic acid corresponds to nucleic acids (DNA and RNA) contained in cells or particles of the above-mentioned target microorganism;

the liquid biological sample is a liquid sample comprising a target microorganism selected from the group consisting of: amniotic fluid, aqueous humor, bile, blood, mammary secretion, bronchopulmonary lavage fluid, cerebrospinal fluid, chyme, stool, interstitial fluid, lymph, menstrual fluid, mucus, plasma, pleural fluid, pus, saliva, sebum, sperm, serum, sputum, sweat, synovial fluid, tears, urine, and vitreous fluid.

Compared with the prior art, the invention has the beneficial effects that:

(1) the present invention combines the use of different chemical reagents to achieve the removal of host nucleic acids from a liquid biological sample, such as blood, from a small (1mL) to a large volume (5mL) of the liquid biological sample, making it possible to identify very small amounts of target microorganisms in the sample using molecular biology methods, e.g., detecting bacteria in amounts as low as 2.0 CFU/mL;

(2) the effective final concentration of the saponin used in the lysis of the host cells in the liquid biological sample is between 0.02% and 1.7%, and when the final concentration of the saponin is more than 1.7%, the extraction yield of the target microbial nucleic acid is reduced dramatically, even to the extent that the target microbial nucleic acid cannot be detected;

(3) the invention determines that the optimal final concentration of the saponin in the mixed solution formed by the saponin and the liquid biological sample is not more than 0.85 percent, otherwise, the yield of the extraction of the target microorganism nucleic acid is reduced;

(4) the method of the invention can detect pathogenic bacteria with the concentration as low as about 2.0CFU/mL, and meet the clinical diagnosis requirement of infectious diseases such as blood stream infection;

(5) the invention has the advantages of less reagent and equipment, low cost, simple process and wide application range;

(6) the sample is treated by nuclease for 2 times, the process greatly reduces the number of nuclease needed for digesting host nucleic acid and the time consumed by reaction, protects the target microorganism in the sample to the maximum extent, and obtains good target microorganism nucleic acid extraction benefit;

(7) the third precipitate contains part or all of the target microorganisms in the liquid biological sample treated by the method of the present invention, and can be used for further detecting and/or quantifying the target microorganisms in the liquid biological sample, and the detection and/or quantification methods include, but are not limited to, Polymerase Chain Reaction (PCR), reverse transcription-polymerase chain reaction (RT-PCR), nucleic acid hybridization-based reactions such as DNA chip hybridization, etc., DNA sequencing, and microorganism culture identification;

(8) the method of the invention may also be applied in the preparation of diagnostic kits.

Drawings

FIG. 1 is a graph showing the effect of saponin concentration on the recovery efficiency of bacteria in test example 1;

FIG. 2 shows the recovery of different amounts of bacteria in test example 2;

FIG. 3 shows the recovery of different amounts of bacteria in test example 3.

Detailed Description

In order to make those skilled in the art better understand the technical solution of the present invention, the following detailed description of the present invention is provided with reference to specific embodiments.

Example 1

A method for selectively removing host nucleic acids from a liquid biological sample, the method comprising the steps of:

(1) uniformly mixing a liquid biological sample with a saponin solution, standing for 5 minutes at room temperature to ensure that cells of non-target components such as host cells and the like are specifically cracked to obtain a mixture, wherein the final concentration of the saponin in the mixture is 1.7%;

(2) centrifuging the mixture at a high speed, and pouring out supernatant after centrifugation to obtain a first precipitate, wherein the rotation speed of the centrifugation is 4000rpm, and the time is 30 minutes;

(3) adding a nuclease reaction solution and a nuclease into the first precipitate, wherein the nuclease contains 10 enzyme units and aims at degrading non-target components in the sample and takes host nucleic acid as main component; enriching the target microorganism 1 after the step (3), and washing the target microorganism 1 by using water and/or a biological buffer solution, wherein the biological buffer solution is PBS; repeating the step (3) for 3 times, specifically, uniformly mixing the first precipitate obtained in the step (2) with nuclease reaction liquid and nuclease, placing the mixture at 37 ℃ for reaction for 30 minutes, then centrifuging the mixture at 12000rpm for 5 minutes, discarding supernatant to obtain a second precipitate, repeating the operation for three times without centrifuging the mixture for the third time;

(4) inactivating nuclease, wherein the method for inactivating nuclease comprises adding EDTA;

(5) the target microorganism 2 is enriched.

Use of a method for selectively removing host nucleic acids from a liquid biological sample in the preparation of a diagnostic kit.

The diagnostic kit is used for isolating a microorganism of interest and/or isolating a nucleic acid of a microorganism of interest in a liquid biological sample comprising the microorganism of interest, non-target cells and optionally fragments of the microorganism of interest and/or non-target cells, the diagnostic kit comprising at least one saponin preparation, at least one enzyme capable of cleaving nucleic acids, EDTA and/or EGTA and/or DTT and/or β -mercaptoethanol and/or DEPC and/or guanidine.

Example 2

A method for selectively removing host nucleic acids from a liquid biological sample, the method comprising the steps of:

(1) uniformly mixing a liquid biological sample with a saponin solution, standing at room temperature for 10 minutes to ensure that cells of non-target components such as host cells and the like are specifically cracked to obtain a mixture, wherein the final concentration of the saponin in the mixture is 0.04%;

(2) centrifuging the mixture at high speed, and pouring out the supernatant after centrifugation to obtain a first precipitate, wherein the rotation speed of the centrifugation is 4200rpm, and the time is 28 minutes;

(3) adding a nuclease reaction solution and a nuclease into the first precipitate, wherein the nuclease comprises 50 enzyme units and aims at degrading non-target components in the sample and takes host nucleic acid as main components; enriching the target microorganism 1 after the step (3), and washing the target microorganism 1 by using water and/or a biological buffer solution, wherein the biological buffer solution is PBS; repeating the step (3) for 2 times, specifically, uniformly mixing the first precipitate obtained in the step (2) with nuclease reaction liquid and nuclease, placing the mixture at 37 ℃ for reaction for 30 minutes, then centrifuging the mixture at 12000rpm for 5 minutes, and removing supernatant to obtain a second precipitate; adding nucleic acid reaction enzyme and nuclease into the second precipitate, uniformly mixing, and reacting at 37 ℃ for 30 minutes;

(4) inactivating nuclease, wherein the method for inactivating nuclease comprises adding EDTA;

(5) the target microorganism 2 is enriched.

Use of a method for selectively removing host nucleic acids from a liquid biological sample in the preparation of a diagnostic kit.

The diagnostic kit is used for isolating a microorganism of interest and/or isolating a nucleic acid of a microorganism of interest in a liquid biological sample comprising the microorganism of interest, non-target cells and optionally fragments of the microorganism of interest and/or non-target cells, the diagnostic kit comprising at least one saponin preparation, at least one enzyme capable of cleaving nucleic acids, EDTA and/or EGTA and/or DTT and/or β -mercaptoethanol and/or DEPC and/or guanidine.

Example 3

A method for selectively removing host nucleic acids from a liquid biological sample, the method comprising the steps of:

(1) uniformly mixing a liquid biological sample and a saponin solution, standing for 15 minutes at room temperature to ensure that cells of non-target components such as host cells and the like are specifically cracked to obtain a mixture, wherein the final concentration of the saponin in the mixture is 0.85%;

(2) centrifuging the mixture at high speed, and pouring out the supernatant after centrifugation to obtain a first precipitate, wherein the rotation speed of the centrifugation is 4500rpm, and the time is 26 minutes;

(3) adding a nuclease reaction solution and a nuclease into the first precipitate, wherein the nuclease comprises 100 enzyme units and aims at degrading non-target components in the sample and takes host nucleic acid as main components; enriching the target microorganism 1 after the step (3), and washing the target microorganism 1 by using water and/or a biological buffer solution, wherein the biological buffer solution is PBS; repeating the step (3) for 2 times, specifically, uniformly mixing the first precipitate obtained in the step (2) with nuclease reaction liquid and nuclease, placing the mixture at 37 ℃ for reaction for 30 minutes, then centrifuging the mixture at 12000rpm for 5 minutes, and removing supernatant to obtain a second precipitate; adding nucleic acid reaction enzyme and nuclease into the second precipitate, uniformly mixing, and reacting at 37 ℃ for 30 minutes;

(4) inactivating nuclease, wherein the method for inactivating nuclease comprises adding EDTA;

(5) the target microorganism 2 is enriched.

Use of a method for selectively removing host nucleic acids from a liquid biological sample in the preparation of a diagnostic kit.

The diagnostic kit is used for isolating a microorganism of interest and/or isolating a nucleic acid of a microorganism of interest in a liquid biological sample comprising the microorganism of interest, non-target cells and optionally fragments of the microorganism of interest and/or non-target cells, the diagnostic kit comprising at least one saponin preparation, at least one enzyme capable of cleaving nucleic acids, EDTA and/or EGTA and/or DTT and/or β -mercaptoethanol and/or DEPC and/or guanidine.

Example 4

A method for selectively removing host nucleic acids from a liquid biological sample, the method comprising the steps of:

(1) uniformly mixing a liquid biological sample with a saponin solution, standing for 20 minutes at room temperature to ensure that cells of non-target components such as host cells and the like are specifically cracked to obtain a mixture, wherein the final concentration of the saponin in the mixture is 1.0 percent;

(2) centrifuging the mixture at a high speed, and pouring out the supernatant after centrifugation to obtain a first precipitate, wherein the rotation speed of the centrifugation is 4800rpm, and the time is 24 minutes;

(3) adding a nuclease reaction solution and a nuclease into the first precipitate, wherein the nuclease contains 150 enzyme units and aims at degrading non-target components in the sample and takes host nucleic acid as main component; enriching the target microorganism 1 after the step (3), and washing the target microorganism 1 by using water and/or a biological buffer solution, wherein the biological buffer solution is PBS; repeating the step (3) for 2 times, specifically, uniformly mixing the first precipitate obtained in the step (2) with nuclease reaction liquid and nuclease, placing the mixture at 37 ℃ for reaction for 30 minutes, then centrifuging the mixture at 12000rpm for 5 minutes, and removing supernatant to obtain a second precipitate; adding nuclease reaction liquid and nuclease into the second precipitate, uniformly mixing, and reacting at 37 ℃ for 30 minutes;

(4) inactivating nuclease, wherein the method for inactivating nuclease comprises adding EDTA;

(5) the target microorganism 2 is enriched.

Use of a method for selectively removing host nucleic acids from a liquid biological sample in the preparation of a diagnostic kit.

The diagnostic kit is used for isolating a microorganism of interest and/or isolating a nucleic acid of a microorganism of interest in a liquid biological sample comprising the microorganism of interest, non-target cells and optionally fragments of the microorganism of interest and/or non-target cells, the diagnostic kit comprising at least one saponin preparation, at least one enzyme capable of cleaving nucleic acids, EDTA and/or EGTA and/or DTT and/or β -mercaptoethanol and/or DEPC and/or guanidine.

Example 5

A method for selectively removing host nucleic acids from a liquid biological sample, the method comprising the steps of:

(1) uniformly mixing a liquid biological sample with a saponin solution, standing at room temperature for 30 minutes to ensure that cells of non-target components such as host cells and the like are specifically cracked to obtain a mixture, wherein the final concentration of the saponin in the mixture is 0.02%;

(2) centrifuging the mixture at a high speed, and pouring out supernatant after centrifugation to obtain a first precipitate, wherein the rotation speed of the centrifugation is 10000rpm, and the time is 20 minutes;

(3) adding a nuclease reaction solution and a nuclease into the first precipitate, wherein the nuclease comprises 200 enzyme units and aims at degrading non-target components in the sample and takes host nucleic acid as the main component; enriching the target microorganism 1 after the step (3), and washing the target microorganism 1 by using water and/or a biological buffer solution, wherein the biological buffer solution is PBS; repeating the step (3) for 1 time, specifically, uniformly mixing the first precipitate obtained in the step (2) with nuclease reaction solution and nuclease, and reacting at 37 ℃ for 30 minutes;

(4) inactivating nuclease, wherein the method for inactivating nuclease comprises adding EDTA;

(5) the target microorganism 2 is enriched.

Use of a method for selectively removing host nucleic acids from a liquid biological sample in the preparation of a diagnostic kit.

The diagnostic kit is used for isolating a microorganism of interest and/or isolating a nucleic acid of a microorganism of interest in a liquid biological sample comprising the microorganism of interest, non-target cells and optionally fragments of the microorganism of interest and/or non-target cells, the diagnostic kit comprising at least one saponin preparation, at least one enzyme capable of cleaving nucleic acids, EDTA and/or EGTA and/or DTT and/or β -mercaptoethanol and/or DEPC and/or guanidine.

Test example 1

Effect of saponin concentration on bacterial recovery efficiency: to 3000. mu.L of aqueous saponin solution, 1000. mu.L of E.coli-containing medium containing 1000CFU of bacteria was added in a series of 15mL sterile centrifuge tubes. The samples were mixed by inversion to give final concentrations of saponin in the mixed solution of 0%, 0.1%, 0.4%, 0.85%, 1.7%, 2.55%, respectively. After standing at room temperature for 15 minutes, the mixture was centrifuged at 4000rpmHeart for 15 minutes. After aspiration of the supernatant, the pellet was resuspended in 500. mu.L PBS and transferred to a new 1.5mL EP tube, followed by 500. mu.L PBS. Centrifuged at 12,000rpm for 5 minutes and the supernatant was discarded. The precipitate was washed by adding 1mL of PBS, centrifuged at 12,000rpm for 5 minutes, and the supernatant was discarded to obtain a precipitate containing bacteria. Use the workerThe column type bacterial genome DNA extraction kit extracts DNA in the precipitate, and the final product is eluted by using 25 mu L of sterile water. The PCR amplification reaction of the bacterial 16S rRNA gene sequence was performed using 10. mu.L of the eluate to detect the presence of and to approximately quantify the recovered bacteria, and the PCR products were detected using 1% agarose gel electrophoresis.

FIG. 1 is an agarose gel electrophoresis chart showing the effect of saponin concentration (%) on the recovery efficiency of bacteria. The labeled lane M is Marker D2000, and the lane N is the PCR negative control reaction product (the PCR reaction template is ddH)₂O), the PCR reaction products in the remaining lanes are shown in fig. 1. Fig. 1 shows that when the final concentration of saponin in the solution is less than 1.7%, the bacteria in the solution are stably recovered. When the final concentration of saponin in the solution is equal to or greater than 1.7%, the recovery rate of bacteria in the solution is extremely low or recovery fails. Thus, saponins should not be used at a final concentration of more than 1.7% for the purpose of isolating the target microorganism in a liquid biological sample.

Test example 2

Recovery of unequal amounts of Staphylococcus aureus from 1mL of whole blood using saponins and nucleases

In test tubes 1-10, 1mL of human whole blood and varying amounts of Staphylococcus aureus (sau) were mixed as follows.

TABLE 1 Whole blood sample content

3mL of the ACK erythrocyte lysate was added to the 1-10 tube, mixed well and lysed at 4 ℃ for 15 minutes. The tube was centrifuged at 4,000rpm for 20 minutes and the supernatant was discarded. The pellet was resuspended with 500. mu.L of ACK and transferred to a new tube. Add 500. mu.L of ACK, centrifuge at 12,000rpm for 5 minutes, and discard the supernatant. The components are added into a test tube No. 1-8 according to the following formula:

the components are added into a test tube No. 9-10 according to the following formula:

the contents of the tube were mixed well and incubated at 37 ℃ for 30 minutes. To all reactions, 20. mu.L of EDTA (25mM) was added, mixed well and incubated at 65 ℃ for 15 minutes. Centrifuged at 12,000rpm for 5 minutes and the supernatant was discarded. The pellet was washed by adding 1mL of PBS, centrifuged at 12,000rpm for 5min, and the supernatant was discarded, leaving a pellet containing bacteria. Use the workerThe column type bacterial genome DNA extraction kit extracts DNA in the precipitate, and the final product is eluted by using 25 mu L of sterile water. The PCR amplification reaction of the bacterial 16S rRNA gene sequence was performed using 10. mu.L of the eluate to detect the presence of and to approximately quantify the recovered bacteria, and the PCR products were detected using 1% agarose gel electrophoresis.

FIG. 2 is an agarose gel electrophoresis image of the recovery of different numbers of bacteria. The labeled lane M is Marker D2000, and the lane N is the PCR negative control reaction product (the PCR reaction template is ddH)₂O), the PCR reaction products in the remaining lanes correspond to the sample numbers in table 1 as indicated by the icon. Figure 2 shows that different amounts of staphylococcus aureus were efficiently recovered in whole blood at a final saponin concentration of 0.85%. Two different nuclease amounts were used in the experiment: 15 and 20 enzyme units, both of which have no significant zone of bacterial recovery efficiencyOtherwise.

Test example 3

Recovery of unequal amounts of Staphylococcus aureus from 5mL of whole blood using 0.85% saponin and nuclease

In 15mL tubes 1-5, 5mL of human whole blood and unequal amounts of Staphylococcus aureus (sau) were mixed as follows

TABLE 2 Whole blood sample content

5mL of a 1.7% aqueous solution of saponin was added to each sample to achieve a final saponin concentration of 0.85%. Mixing, and standing at room temperature for 5 min. Centrifuge at 4,000rpm for 20 minutes and pour off the supernatant.

After centrifuging sample tube No. 1 at 4,000rpm for 2 minutes, the supernatant was aspirated, leaving a pellet. Add 400. mu.L of sterile water, blow the suspension pellet, transfer to a 1.5mL tube, and add 400. mu.L of sterile water. The components are added according to the following formula:

the following ingredients were added to sample tubes No. 2-5:

after mixing, incubation was carried out at 37 ℃ for 30 minutes. After centrifugation at 4,000rpm for 5 minutes, the whole of the liquid and the precipitate were transferred to a 1.5mL test tube, and 400. mu.L of sterile water was added. After centrifugation at 12,000rpm for 5 minutes, the supernatant was discarded, leaving a precipitate.

The ingredients were added to all sample tubes according to the following recipe:

the samples were mixed well and incubated at 37 ℃ for 30 min. To the sample was added 25. mu.L of 100mM EDTA, mixed well and left at room temperature for 5 minutes. Centrifuged at 12,000rpm for 5 minutes and the supernatant was discarded. 1mL of H was added₂The pellet was washed with O, centrifuged at 12,000rpm for 5 minutes, and the supernatant was discarded, leaving a pellet containing the bacteria. Use the workerThe column type bacterial genome DNA extraction kit extracts DNA in the precipitate, and the final product is eluted by using 25 mu L of sterile water. The PCR amplification reaction of the bacterial 16S rRNA gene sequence was performed using 10. mu.L of the eluate to detect the presence of and to approximately quantify the recovered bacteria, and the PCR products were detected using 1% agarose gel electrophoresis.

FIG. 3 is an agarose gel electrophoresis image of the recovery of different numbers of bacteria. The labeled lane M is Marker D2000, and the lane N is the PCR negative control reaction product (the PCR reaction template is ddH)₂O), lane P is a positive control (the PCR reaction template is a DNA fragment of the bacterial 16S rRNA gene), and the PCR reaction products in the remaining lanes correspond to the sample numbers shown in Table 2. FIG. 3 shows that different amounts of Staphylococcus aureus were efficiently recovered in whole blood at a final saponin concentration of 0.85%. At the first nuclease digestion in the experiment, two different nuclease concentrations were used: 150U/1050. mu.L and 150U/650. mu.L, the latter being significantly less efficient in bacterial recovery than the former. Experiments show that the bacteria content of samples with bacteria recovery can be detected to be as low as 2 CFU/mL.

Test example 4

Recovery of unequal amounts of Staphylococcus aureus from 5mL of whole blood using 1.70% saponin and nuclease

To 5mL of whole blood anticoagulated with EDTA, 1500, 750, 375, 188, 94, 47, 24, 12,0 (negative control) of Staphylococcus aureus was added in a 15mL sterile centrifuge tube, and the number of CFU of bacteria was confirmed by plating on a blood agar plate. 5mL of each tube was addedThe filtered 1.70% saponin solution is mixed by inverting the centrifugal tube, reacted at room temperature for 5min, centrifuged at 3200g for 20min, and the supernatant is discarded. To the precipitate were added 800. mu.L of sterile water, 100. mu.L of Buffer (100mM Tris-HCl (pH 7.5at 25 ℃ C.), 25mM MgCl₂,1mM CaCl₂) And 150. mu.L of DNase I (1U/. mu.L), vortexing the solution and precipitate, and reacting at 37 ℃ for 30min, vortexing once every 5 min. The reaction mixture was transferred to a 1.5mL tube, centrifuged at 12000rpm for 5min, the supernatant was discarded, and 400. mu.L of sterile water and 50. mu.L of Buffer (100mM Tris-HCl (pH 7.5at 25 ℃ C.), 25mM MgCl, were added again₂,1mM CaCl₂) And 50. mu.L of DNase I (1U/. mu.L), vortexing the solution and precipitate, and reacting at 37 ℃ for 30min, vortexing once every 5 min. To the solution was added 25. mu.L of 100mM EDTA and vortexed to mix. Centrifuging at 12000rpm for 5min, and discarding the supernatant. Use the workerThe column type bacterial genome DNA extraction kit extracts DNA in the precipitate, and the final product is eluted by using 25 mu L of sterile water.

PCR amplification was performed using 10. mu.L of the eluate, and the amplified product was species-identified using sequencing techniques. Sequence information of staphylococcus aureus was identified in samples with staphylococcus aureus added at 1500, 750, 375, 188, 94, 47, 24, 12CFU, but not in samples with staphylococcus aureus added at 0 (negative control) CFU. Experiments show that the bacteria content of the sample with the bacteria recovery detectable can be as low as 2.5 CFU/mL.

The above examples and test examples only express the specific embodiments of the present application, and the description thereof is specific and detailed, but not construed as limiting the scope of the present application. It should be noted that, for those skilled in the art, without departing from the technical idea of the present application, several changes and modifications can be made, which are all within the protection scope of the present application.